AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Redcare Pharmacy N.V.

Director's Dealing Jun 6, 2025

6219_dirs_2025-06-06_0c4e18c4-e6c5-4479-ba2b-c66f81b66798.html

Director's Dealing

Open in Viewer

Opens in native device viewer

News Details

Directors’ Dealings | 6 June 2025 10:03

Redcare Pharmacy N.V.: Lode Fastre, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

06.06.2025 / 10:02 CET/CEST

The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:
First name: Lode
Last name(s): Fastre

2. Reason for the notification

a) Position / status

Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Redcare Pharmacy N.V.

b) LEI

529900JK6UXHY1YKZ082

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type: Share
ISIN: NL0012044747

b) Nature of the transaction

Acquisition

c) Price(s) and volume(s)

Price(s) Volume(s)
100.00 EUR 100,000.00 EUR

d) Aggregated information

Price Aggregated volume
100.0000 EUR 100,000.0000 EUR

e) Date of the transaction

05/06/2025; UTC+2

f) Place of the transaction

Name: XETRA
MIC: XETR

06.06.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com


Language: English
Company: Redcare Pharmacy N.V.
Erik de Rodeweg 11-13
5975 WD Sevenum
Netherlands
Internet: www.redcare-pharmacy.com
End of News EQS News Service

99220  06.06.2025 CET/CEST

Talk to a Data Expert

Have a question? We'll get back to you promptly.